{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:58:39Z","timestamp":1792457919339,"version":"4.5.0"},"reference-count":89,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,8,19]],"date-time":"2022-08-19T00:00:00Z","timestamp":1660867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,8,19]],"date-time":"2022-08-19T00:00:00Z","timestamp":1660867200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["1K01MH122326"],"award-info":[{"award-number":["1K01MH122326"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr HIV\/AIDS Rep"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1007\/s11904-022-00621-1","type":"journal-article","created":{"date-parts":[[2022,8,19]],"date-time":"2022-08-19T13:03:48Z","timestamp":1660914228000},"page":"293-300","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["HIV Prevention Tools Across the Pregnancy Continuum: What Works, What Does Not, and What Can We Do Differently?"],"prefix":"10.1007","volume":"19","author":[{"given":"Melissa Latigo","family":"Mugambi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jillian","family":"Pintye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renee","family":"Heffron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruanne Vanessa","family":"Barnabas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace","family":"John-Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,19]]},"reference":[{"key":"621_CR1","unstructured":"UNAIDS D. UNAIDS 2020 Global Report, UNAIDS Joint United Nations Programme on HIV. Geneva: AIDS; 2020."},{"key":"621_CR2","unstructured":"Rosenberg NE, et al. Empirical estimates of adult HIV incidence across 12 countries in sub-Saharan Africa. in CROI. 2022."},{"issue":"5","key":"621_CR3","doi-asserted-by":"publisher","first-page":"e0125525","DOI":"10.1371\/journal.pone.0125525","volume":"10","author":"T-H Dinh","year":"2015","unstructured":"Dinh T-H, et al. Impact of maternal HIV seroconversion during pregnancy on early mother to child transmission of HIV (MTCT) measured at 4\u20138 weeks postpartum in South Africa 2011\u20132012: a national population-based evaluation. PLoS\u00a0One. 2015;10(5):e0125525\u2013e0125525.","journal-title":"PLoS ONE"},{"issue":"1","key":"621_CR4","doi-asserted-by":"publisher","first-page":"e054397","DOI":"10.1136\/bmjopen-2021-054397","volume":"12","author":"ZT Tessema","year":"2022","unstructured":"Tessema ZT, et al. Determinants of accessing healthcare in Sub-Saharan Africa: a mixed-effect analysis of recent demographic and health surveys from 36 countries. BMJ Open. 2022;12(1):e054397\u2013e054397.","journal-title":"BMJ Open"},{"key":"621_CR5","unstructured":"WHO, Preventing HIV during pregnancy and breastfeeding in the context of PrEP. 2017, World Health Organization: Geneva, Switzerland."},{"key":"621_CR6","doi-asserted-by":"crossref","unstructured":"Worku MG, Teshale AB, Tesema GA. Prevalence and associated factors of HIV testing among pregnant women: a multilevel analysis using the recent demographic and health survey data from 11 East African countries. HIV\/AIDS (Auckland, N.Z.) 2021;13:181\u2013189.","DOI":"10.2147\/HIV.S297235"},{"issue":"11","key":"621_CR7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0242001","volume":"15","author":"OE Awopegba","year":"2020","unstructured":"Awopegba OE, et al. Prenatal care coverage and correlates of HIV testing in sub-Saharan Africa: insight from demographic and health surveys of 16 countries. PLoS\u00a0One. 2020;15(11): e0242001.","journal-title":"PLoS ONE"},{"issue":"3","key":"621_CR8","doi-asserted-by":"publisher","first-page":"S83","DOI":"10.1016\/j.ajog.2007.03.006","volume":"197","author":"OO Bolu","year":"2007","unstructured":"Bolu OO, et al. Approaches for scaling up human immunodeficiency virus testing and counseling in prevention of mother-to-child human immunodeficiency virus transmission settings in resource-limited countries. Am J Obstet Gynecol. 2007;197(3):S83\u20139.","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"621_CR9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0144618","volume":"11","author":"S Ndege","year":"2016","unstructured":"Ndege S, et al. HIV prevalence and antenatal care attendance among pregnant women in a large home-based HIV counseling and testing program in Western Kenya. PLoS\u00a0One. 2016;11(1): e0144618.","journal-title":"PLoS ONE"},{"issue":"1","key":"621_CR10","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1186\/s12884-020-03197-z","volume":"20","author":"M Nakanwagi","year":"2020","unstructured":"Nakanwagi M, et al. Low proportion of women who came knowing their HIV status at first antenatal care visit, Uganda, 2012\u20132016: a descriptive analysis of surveillance data. BMC Pregnancy Childbirth. 2020;20(1):498.","journal-title":"BMC Pregnancy Childbirth"},{"issue":"3","key":"621_CR11","doi-asserted-by":"publisher","first-page":"e0192982","DOI":"10.1371\/journal.pone.0192982","volume":"13","author":"D Joseph Davey","year":"2018","unstructured":"Joseph Davey D, et al. Sexual risk during pregnancy and postpartum periods among HIV-infected and -uninfected South African women: implications for primary and secondary HIV prevention interventions. PLoS\u00a0One. 2018;13(3):e0192982\u2013e0192982.","journal-title":"PLoS ONE"},{"key":"621_CR12","doi-asserted-by":"crossref","unstructured":"Thomson K, et al. Increased risk of female HIV-1 acquisition throughout pregnancy and postpartum: a prospective per-coital act analysis among women with HIV-1 infected partners. J Infect Dis. 2018.","DOI":"10.1093\/infdis\/jiy113"},{"issue":"10","key":"621_CR13","doi-asserted-by":"publisher","first-page":"e977","DOI":"10.1016\/S2214-109X(17)30325-X","volume":"5","author":"A-B Moller","year":"2017","unstructured":"Moller A-B, et al. Early antenatal care visit: a systematic analysis of regional and global levels and trends of coverage from 1990 to 2013. Lancet Glob Health. 2017;5(10):e977\u201383.","journal-title":"Lancet Glob Health"},{"issue":"1","key":"621_CR14","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1186\/s12978-021-01282-w","volume":"18","author":"M Munthali","year":"2021","unstructured":"Munthali M, et al. Knowledge and perceptions of preconception care among health workers and women of reproductive age in Mzuzu City, Malawi: a cross-sectional study. Reprod Health. 2021;18(1):229.","journal-title":"Reprod Health"},{"issue":"7","key":"621_CR15","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-035937","volume":"10","author":"F Teshome","year":"2020","unstructured":"Teshome F, et al. What do women know before getting pregnant? Knowledge of preconception care and associated factors among pregnant women in Mana district, Southwest Ethiopia: a community-based cross-sectional study. BMJ Open. 2020;10(7): e035937.","journal-title":"BMJ Open"},{"issue":"1","key":"621_CR16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1742-4755-10-1","volume":"10","author":"SV Dean","year":"2013","unstructured":"Dean SV, et al. Born too soon: care before and between pregnancy to prevent preterm births: from evidence to action. Reprod Health. 2013;10(1):1\u201316.","journal-title":"Reprod Health"},{"issue":"12","key":"621_CR17","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-052311","volume":"11","author":"ML Mugambi","year":"2021","unstructured":"Mugambi ML, et al. Design and evaluation of strategies to implement HIV prevention interventions for pregnant women in community pharmacy settings in western Kenya: a mixed-methods study protocol. BMJ Open. 2021;11(12): e052311.","journal-title":"BMJ Open"},{"issue":"6","key":"621_CR18","first-page":"751","volume":"64","author":"J Pintye","year":"2017","unstructured":"Pintye J, et al. A risk assessment tool for identifying pregnant and postpartum women who may benefit from preexposure prophylaxis. Clin Infect Dis. 2017;64(6):751\u20138.","journal-title":"Clin Infect Dis"},{"key":"621_CR19","doi-asserted-by":"crossref","unstructured":"Balkus JE, et al. An empiric HIV risk scoring tool to predict HIV-1 acquisition in African women. J Acquir Immune Defic Syndr. (1999), 2016;72(3):333.","DOI":"10.1097\/QAI.0000000000000974"},{"key":"621_CR20","doi-asserted-by":"crossref","unstructured":"Kahle EM, et al. An empiric risk scoring tool for identifying high-risk heterosexual HIV-1 serodiscordant couples for targeted HIV-1 prevention. J Acquir Immune Defic Syndr. (1999), 2013;62(3):339.","DOI":"10.1097\/QAI.0b013e31827e622d"},{"issue":"9639","key":"621_CR21","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/S0140-6736(08)60886-7","volume":"372","author":"TJ Coates","year":"2008","unstructured":"Coates TJ, Richter L, Caceres C. Behavioural strategies to reduce HIV transmission: how to make them work better. The Lancet. 2008;372(9639):669\u201384.","journal-title":"The Lancet"},{"key":"621_CR22","unstructured":"Organization, W.H. Prevention of mother-to-child transmission (PMTCT). Briefing Note. Geneva: Department of HIV\/AIDS, 2007."},{"key":"621_CR23","unstructured":"World Health Organization, Guidance on couples HIV testing and counselling including antiretroviral therapy for treatment and prevention in serodiscordant couples: recommendations for a public health approach. 2012."},{"issue":"1","key":"621_CR24","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1186\/1471-2458-10-197","volume":"10","author":"J Orne-Gliemann","year":"2010","unstructured":"Orne-Gliemann J, et al. Couple-oriented prenatal HIV counseling for HIV primary prevention: an acceptability study. BMC Public Health. 2010;10(1):197.","journal-title":"BMC Public Health"},{"issue":"10","key":"621_CR25","doi-asserted-by":"publisher","first-page":"e0240087","DOI":"10.1371\/journal.pone.0240087","volume":"15","author":"J Clark","year":"2020","unstructured":"Clark J, et al. Improving male involvement in antenatal care in low and middle-income countries to prevent mother to child transmission of HIV: A realist review. PLoS\u00a0One. 2020;15(10):e0240087\u2013e0240087.","journal-title":"PLoS ONE"},{"issue":"10290","key":"621_CR26","doi-asserted-by":"publisher","first-page":"2130","DOI":"10.1016\/S0140-6736(21)01163-6","volume":"397","author":"M Cornell","year":"2021","unstructured":"Cornell M, et al. HIV services in sub-Saharan Africa: the greatest gap is men. The Lancet. 2021;397(10290):2130\u20132.","journal-title":"The Lancet"},{"issue":"5","key":"621_CR27","doi-asserted-by":"publisher","first-page":"e284","DOI":"10.1016\/S2352-3018(20)30315-5","volume":"8","author":"K Gigu\u00e8re","year":"2021","unstructured":"Gigu\u00e8re K, et al. Trends in knowledge of HIV status and efficiency of HIV testing services in sub-Saharan Africa, 2000\u201320: a modelling study using survey and HIV testing programme data. The Lancet HIV. 2021;8(5):e284\u201393.","journal-title":"The Lancet HIV"},{"issue":"12","key":"621_CR28","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1097\/QAD.0b013e328348fb85","volume":"25","author":"BK Mohlala","year":"2011","unstructured":"Mohlala BK, Boily MC, Gregson S. The forgotten half of the equation: randomized controlled trial of a male invitation to attend couple voluntary counselling and testing. AIDS. 2011;25(12):1535\u201341.","journal-title":"AIDS"},{"issue":"2","key":"621_CR29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0212119","volume":"14","author":"J Homsy","year":"2019","unstructured":"Homsy J, et al. Primary HIV prevention in pregnant and lactating Ugandan women: a randomized trial. PLoS\u00a0One. 2019;14(2): e0212119.","journal-title":"PLoS ONE"},{"key":"621_CR30","doi-asserted-by":"crossref","unstructured":"Choko AT, et al. Partner-delivered HIV self-test kits with and without financial incentives in antenatal care and index patients with HIV in Malawi: a three-arm, cluster-randomised controlled trial. Lancet Global Health. 2021;9(7):e977\u2013e988. This three-arm cluster randomized trial in Malawi found an increase in HIV testing rates among male partners who received HIV self-tests from pregnant women attending antenatal care.","DOI":"10.1016\/S2214-109X(21)00175-3"},{"issue":"11","key":"621_CR31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002166","volume":"13","author":"SH Masters","year":"2016","unstructured":"Masters SH, et al. Promoting partner testing and couples testing through secondary distribution of HIV self-tests: a randomized clinical trial. PLoS Med. 2016;13(11): e1002166.","journal-title":"PLoS Med"},{"issue":"7","key":"621_CR32","doi-asserted-by":"publisher","first-page":"e977","DOI":"10.1016\/S2214-109X(21)00175-3","volume":"9","author":"AT Choko","year":"2021","unstructured":"Choko AT, et al. Partner-delivered HIV self-test kits with and without financial incentives in antenatal care and index patients with HIV in Malawi: a three-arm, cluster-randomised controlled trial. Lancet Glob Health. 2021;9(7):e977\u201388.","journal-title":"Lancet Glob Health"},{"key":"621_CR33","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.25293","volume":"22","author":"RB Hershow","year":"2019","unstructured":"Hershow RB, et al. Perspectives on HIV partner notification, partner HIV self-testing and partner home-based HIV testing by pregnant and postpartum women in antenatal settings: a qualitative analysis in Malawi and Zambia. J Int AIDS Soc. 2019;22: e25293.","journal-title":"J Int AIDS Soc"},{"issue":"4","key":"621_CR34","doi-asserted-by":"publisher","first-page":"332","DOI":"10.2989\/16085906.2019.1686032","volume":"18","author":"JE Korte","year":"2019","unstructured":"Korte JE, et al. HIV testing preferences among pregnant women attending antenatal care and their male partners: a discrete choice experiment in Uganda. Afr J AIDS Res. 2019;18(4):332\u201340.","journal-title":"Afr J AIDS Res"},{"key":"621_CR35","unstructured":"Ngumbau NM. HIVST acceptance and PrEP initiation among pregnant women at high risk of HIV in Homa Bay and Siaya counties, Kenya. 2021."},{"key":"621_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2021.100991","volume":"38","author":"MS Jamil","year":"2021","unstructured":"Jamil MS, et al. Examining the effects of HIV self-testing compared to standard HIV testing services in the general population: a systematic review and meta-analysis. EClinicalMedicine. 2021;38: 100991.","journal-title":"EClinicalMedicine"},{"issue":"12","key":"621_CR37","doi-asserted-by":"publisher","first-page":"e1632","DOI":"10.1016\/S2214-109X(21)00450-2","volume":"9","author":"EL Sibanda","year":"2021","unstructured":"Sibanda EL, Mavhu W. Secondary HIV self-test distribution increases male partner testing. Lancet Glob Health. 2021;9(12):e1632\u20133.","journal-title":"Lancet Glob Health"},{"issue":"1","key":"621_CR38","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1136\/sti.75.1.3","volume":"75","author":"DT Fleming","year":"1999","unstructured":"Fleming DT, Wasserheit JN. From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sexually transmitted infections. 1999;75(1):3\u201317.","journal-title":"Sexually transmitted infections"},{"key":"621_CR39","unstructured":"World Health Organization. Global guidance on criteria and processes for validation: elimination of mother-to-child transmission (EMTCT) of HIV and syphilis. WHO, Editor. Geneva, Switzerland; 2014."},{"issue":"Suppl 1","key":"621_CR40","doi-asserted-by":"publisher","first-page":"S15","DOI":"10.1016\/j.ijgo.2015.04.008","volume":"130","author":"A Swartzendruber","year":"2015","unstructured":"Swartzendruber A, et al. Introduction of rapid syphilis testing in antenatal care: a systematic review of the impact on HIV and syphilis testing uptake and coverage. Int J Gynaecol Obstet. 2015;130(Suppl 1):S15-21.","journal-title":"Int J Gynaecol Obstet"},{"issue":"2","key":"621_CR41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0211720","volume":"14","author":"EL Korenromp","year":"2019","unstructured":"Korenromp EL, et al. Global burden of maternal and congenital syphilis and associated adverse birth outcomes\u2014estimates for 2016 and progress since 2012. PLoS\u00a0One. 2019;14(2): e0211720.","journal-title":"PLoS ONE"},{"issue":"9551","key":"621_CR42","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1016\/S0140-6736(06)69482-8","volume":"368","author":"N Low","year":"2006","unstructured":"Low N, et al. Global control of sexually transmitted infections. Lancet. 2006;368(9551):2001\u201316.","journal-title":"Lancet"},{"issue":"7","key":"621_CR43","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1097\/OLQ.0000000000000460","volume":"43","author":"DL Joseph Davey","year":"2016","unstructured":"Joseph Davey DL, et al. Prevalence of curable sexually transmitted infections in pregnant women in low- and middle-income countries from 2010 to 2015: a systematic review. Sex Transm Dis. 2016;43(7):450\u20138.","journal-title":"Sex Transm Dis"},{"issue":"3","key":"621_CR44","doi-asserted-by":"publisher","first-page":"e300","DOI":"10.1016\/S2214-109X(16)30362-X","volume":"5","author":"KJ Looker","year":"2017","unstructured":"Looker KJ, et al. First estimates of the global and regional incidence of neonatal herpes infection. Lancet Glob Health. 2017;5(3):e300\u20139.","journal-title":"Lancet Glob Health"},{"key":"621_CR45","unstructured":"World Health Organization. Guidelines for the management of sexually transmitted infections. Revised 2003. WHO Library Cataloguing-in-Publication Data. Geneva, Switzerland."},{"issue":"1","key":"621_CR46","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1093\/infdis\/jis298","volume":"206","author":"K Mlisana","year":"2012","unstructured":"Mlisana K, et al. Symptomatic vaginal discharge is a poor predictor of sexually transmitted infections and genital tract inflammation in high-risk women in South Africa. J Infect Dis. 2012;206(1):6\u201314.","journal-title":"J Infect Dis"},{"issue":"2","key":"621_CR47","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1046\/j.1365-3156.1999.00360.x","volume":"4","author":"WK Bosu","year":"1999","unstructured":"Bosu WK. Syndromic management of sexually transmitted diseases: is it rational or scientific? Trop Med Int Health. 1999;4(2):114\u20139.","journal-title":"Trop Med Int Health"},{"issue":"5","key":"621_CR48","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1136\/sti.2004.009407","volume":"80","author":"B Vuylsteke","year":"2004","unstructured":"Vuylsteke B. Current status of syndromic management of sexually transmitted infections in developing countries. Sex Transm Infect. 2004;80(5):333\u20134.","journal-title":"Sex Transm Infect"},{"issue":"7","key":"621_CR49","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1136\/sti.2008.032011","volume":"84","author":"RG White","year":"2008","unstructured":"White RG, et al. Low effectiveness of syndromic treatment services for curable sexually transmitted infections in rural South Africa. Sex Transm Infect. 2008;84(7):528\u201334.","journal-title":"Sex Transm Infect"},{"issue":"9192","key":"621_CR50","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1016\/S0140-6736(99)02463-0","volume":"354","author":"S Hawkes","year":"1999","unstructured":"Hawkes S, et al. Reproductive-tract infections in women in low-income, low-prevalence situations: assessment of syndromic management in Matlab, Bangladesh. Lancet. 1999;354(9192):1776\u201381.","journal-title":"Lancet"},{"key":"621_CR51","doi-asserted-by":"publisher","first-page":"3946862","DOI":"10.1155\/2018\/3946862","volume":"2018","author":"E Morikawa","year":"2018","unstructured":"Morikawa E, et al. Acceptability and feasibility of integrating point-of-care diagnostic testing of sexually transmitted infections into a South African antenatal care program for HIV-infected pregnant women. Infect Dis Obstet Gynecol. 2018;2018:3946862.","journal-title":"Infect Dis Obstet Gynecol"},{"key":"621_CR52","doi-asserted-by":"publisher","first-page":"1251238","DOI":"10.1155\/2016\/1251238","volume":"2016","author":"A Wynn","year":"2016","unstructured":"Wynn A, et al. Acceptability and feasibility of sexually transmitted infection testing and treatment among pregnant women in Gaborone, Botswana, 2015. Biomed Res Int. 2016;2016:1251238.","journal-title":"Biomed Res Int"},{"issue":"1","key":"621_CR53","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1097\/OLQ.0000000000001517","volume":"49","author":"A Wynn","year":"2022","unstructured":"Wynn A, et al. Bridging the gap between pilot and scale-up: a model of antenatal testing for curable sexually transmitted infections from Botswana. Sex Transm Dis. 2022;49(1):59\u201366.","journal-title":"Sex Transm Dis"},{"issue":"11","key":"621_CR54","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1097\/OLQ.0000000000000355","volume":"42","author":"JA Unger","year":"2015","unstructured":"Unger JA, et al. Patient-delivered partner treatment for chlamydia, gonorrhea, and trichomonas infection among pregnant and postpartum women in Kenya. Sex Transm Dis. 2015;42(11):637.","journal-title":"Sex Transm Dis"},{"key":"621_CR55","doi-asserted-by":"crossref","unstructured":"Weller SC, Davis-Beaty K. Condom effectiveness in reducing heterosexual HIV transmission. Cochrane Database System Rev. 2002(1).","DOI":"10.1002\/14651858.CD003255"},{"issue":"6","key":"621_CR56","first-page":"454","volume":"82","author":"KK Holmes","year":"2004","unstructured":"Holmes KK, Levine R, Weaver M. Effectiveness of condoms in preventing sexually transmitted infections. Bull World Health Organ. 2004;82(6):454\u201361.","journal-title":"Bull World Health Organ"},{"issue":"7","key":"621_CR57","doi-asserted-by":"publisher","first-page":"3277","DOI":"10.1007\/s10508-021-02062-0","volume":"50","author":"S Theuring","year":"2021","unstructured":"Theuring S, et al. Sexual risk behavior in HIV-uninfected pregnant women in Western Uganda. Arch Sex Behav. 2021;50(7):3277\u201386.","journal-title":"Arch Sex Behav"},{"issue":"15","key":"621_CR58","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1097\/QAD.0000000000000793","volume":"29","author":"J Kinuthia","year":"2015","unstructured":"Kinuthia J, et al. HIV acquisition during pregnancy and postpartum is associated with genital infections and partnership characteristics. AIDS. 2015;29(15):2025\u201333.","journal-title":"AIDS"},{"issue":"1","key":"621_CR59","doi-asserted-by":"publisher","first-page":"6","DOI":"10.2989\/16085906.2021.1872663","volume":"20","author":"R Maharajh","year":"2021","unstructured":"Maharajh R, Haffejee F. Exploring male condom use among women in South Africa: a review of the literature. Afr J AIDS Res. 2021;20(1):6\u201314.","journal-title":"Afr J AIDS Res"},{"issue":"1","key":"621_CR60","doi-asserted-by":"publisher","first-page":"61","DOI":"10.2989\/16085906.2021.1872664","volume":"20","author":"JC Chapola","year":"2021","unstructured":"Chapola JC, et al. Women\u2019s perspectives on relationship dynamics with their partners and their role in HIV acquisition, HIV disclosure, hormonal contraceptive uptake, and condom use. Afr J AIDS Res. 2021;20(1):61\u20139.","journal-title":"Afr J AIDS Res"},{"issue":"5","key":"621_CR61","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0197143","volume":"13","author":"D Joseph Davey","year":"2018","unstructured":"Joseph Davey D, et al. Risk perception and sex behaviour in pregnancy and breastfeeding in high HIV prevalence settings: programmatic implications for PrEP delivery. PLoS\u00a0One. 2018;13(5): e0197143.","journal-title":"PLoS ONE"},{"key":"621_CR62","doi-asserted-by":"publisher","first-page":"125","DOI":"10.2147\/OAJC.S55041","volume":"6","author":"L Moore","year":"2015","unstructured":"Moore L, et al. Knowledge, attitudes, practices and behaviors associated with female condoms in developing countries: a scoping review. Open Access J Contracept. 2015;6:125\u201342.","journal-title":"Open Access J Contracept"},{"issue":"35","key":"621_CR63","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/S0968-8080(10)35499-1","volume":"18","author":"A Peters","year":"2010","unstructured":"Peters A, Jansen W, van Driel F. The female condom: the international denial of a strong potential. Reprod Health Matters. 2010;18(35):119\u201328.","journal-title":"Reprod Health Matters"},{"issue":"1","key":"621_CR64","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1186\/s12889-020-8384-7","volume":"20","author":"AB Wiyeh","year":"2020","unstructured":"Wiyeh AB, et al. Effectiveness of the female condom in preventing HIV and sexually transmitted infections: a systematic review and meta-analysis. BMC Public Health. 2020;20(1):319.","journal-title":"BMC Public Health"},{"issue":"3","key":"621_CR65","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1080\/19317611.2019.1643813","volume":"31","author":"F Haffejee","year":"2019","unstructured":"Haffejee F, Maharajh R. Addressing female condom use among women in South Africa: a review of the literature. Int J Sex Health. 2019;31(3):297\u2013307.","journal-title":"Int J Sex Health"},{"key":"621_CR66","doi-asserted-by":"crossref","unstructured":"Lopez LM, et al. Behavioral interventions for improving condom use for dual protection. Cochrane Database System Rev. 2013(10).","DOI":"10.1002\/14651858.CD010662"},{"key":"621_CR67","doi-asserted-by":"crossref","unstructured":"Moreno R, et al. Structural and community-level interventions for increasing condom use to prevent the transmission of HIV and other sexually transmitted infections. Cochrane Database System Rev. 2014(7).","DOI":"10.1002\/14651858.CD003363.pub3"},{"key":"621_CR68","doi-asserted-by":"crossref","unstructured":"Young Holt B, Turpin JA, Romano J. Multipurpose prevention technologies: opportunities and challenges to ensure advancement of the most promising MPTs. Front Reprod Health. 2021;3.","DOI":"10.3389\/frph.2021.704841"},{"key":"621_CR69","doi-asserted-by":"crossref","unstructured":"Abdool Karim S, et al. The need for multipurpose prevention technologies in sub-Saharan Africa. BJOG: Int J Obstetr Gynaecol. 2014;121:27\u201334.","DOI":"10.1111\/1471-0528.12842"},{"issue":"1","key":"621_CR70","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1186\/s12879-020-05399-4","volume":"20","author":"P Vickerman","year":"2020","unstructured":"Vickerman P, et al. HIV prevention is not all about HIV \u2013 using a discrete choice experiment among women to model how the uptake and effectiveness of HIV prevention products may also rely on pregnancy and STI protection. BMC Infect Dis. 2020;20(1):704.","journal-title":"BMC Infect Dis"},{"issue":"12","key":"621_CR71","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1097\/QAD.0000000000001145","volume":"30","author":"VA Fonner","year":"2016","unstructured":"Fonner VA, et al. Effectiveness and safety of oral HIV preexposure prophylaxis for all populations. AIDS (London, England). 2016;30(12):1973.","journal-title":"AIDS (London, England)"},{"issue":"5","key":"621_CR72","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1056\/NEJMoa1108524","volume":"367","author":"JM Baeten","year":"2012","unstructured":"Baeten JM, et al. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med. 2012;367(5):399\u2013410.","journal-title":"N Engl J Med"},{"key":"621_CR73","unstructured":"Mayer KH, Krakower D. Administration of pre-exposure prophylaxis against HIV infection. UpToDate. Published July, 2019. 16."},{"issue":"1","key":"621_CR74","doi-asserted-by":"publisher","first-page":"e25426","DOI":"10.1002\/jia2.25426","volume":"23","author":"DL Joseph Davey","year":"2020","unstructured":"Joseph Davey DL, et al. Emerging evidence from a systematic review of safety of pre-exposure prophylaxis for pregnant and postpartum women: where are we now and where are we heading? J Int AIDS Soc. 2020;23(1):e25426\u2013e25426.","journal-title":"J Int AIDS Soc"},{"issue":"11","key":"621_CR75","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1080\/14740338.2021.1931680","volume":"20","author":"RM Stalter","year":"2021","unstructured":"Stalter RM, Pintye J, Mugwanya KK. Safety review of tenofovir disoproxil fumarate\/emtricitabine pre-exposure prophylaxis for pregnant women at risk of HIV infection. Expert Opin Drug Saf. 2021;20(11):1367\u201373.","journal-title":"Expert Opin Drug Saf"},{"key":"621_CR76","doi-asserted-by":"crossref","unstructured":"Kinuthia J, et al. Pre-exposure prophylaxis uptake and early continuation among pregnant and post-partum women within maternal and child health clinics in Kenya: results from an implementation programme. Lancet HIV. 2020;7(1):e38\u2013e48. This implementation study of PrEP in maternal and child health clinics in Kenya, found that pregnant and postpartum women who had a partner living with an HIV were more likely to initiate and continue PrEP.","DOI":"10.1016\/S2352-3018(19)30371-6"},{"key":"621_CR77","doi-asserted-by":"crossref","unstructured":"Joseph Davey DL, et al. Early pre-exposure prophylaxis (PrEP) initiation and continuation among pregnant and postpartum women in antenatal care in Cape Town, South Africa. J Int AIDS Soc. 2022;25(2):e25866. This cohort study in South Africa, found high rates or PrEP initiation and continuation among pregnant and postpartum women.","DOI":"10.1002\/jia2.25866"},{"issue":"4","key":"621_CR78","doi-asserted-by":"publisher","first-page":"e83","DOI":"10.1097\/QAI.0000000000002587","volume":"86","author":"J Pintye","year":"2021","unstructured":"Pintye J, et al. Influences on early discontinuation and persistence of daily oral PrEP use among Kenyan adolescent girls and young women: a qualitative evaluation from a PrEP implementation program. JAIDS J Acquir Immune Defic Syndr. 2021;86(4):e83\u20139.","journal-title":"JAIDS J Acquir Immune Defic Syndr"},{"issue":"6","key":"621_CR79","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1071\/SH18067","volume":"15","author":"N Davies","year":"2018","unstructured":"Davies N, Heffron R. Global and national guidance for the use of pre-exposure prophylaxis during peri-conception, pregnancy and breastfeeding. Sexual health. 2018;15(6):501\u201312.","journal-title":"Sexual health"},{"issue":"8","key":"621_CR80","doi-asserted-by":"publisher","first-page":"e582","DOI":"10.1016\/S2352-3018(20)30102-8","volume":"7","author":"J Pintye","year":"2020","unstructured":"Pintye J, et al. Defining gaps in pre-exposure prophylaxis delivery for pregnant and post-partum women in high-burden settings using an implementation science framework. Lancet HIV. 2020;7(8):e582\u201392.","journal-title":"Lancet HIV"},{"key":"621_CR81","unstructured":"Davey DLJ, et al. Where are the pregnant and breastfeeding women in new pre-exposure prophylaxis trials? The imperative to overcome the evidence gap. Lancet HIV. 2022."},{"issue":"S1","key":"621_CR82","first-page":"8","volume":"24","author":"SD Moretlwe","year":"2021","unstructured":"Moretlwe SD, et al. Long acting injectable cabotegravir is safe and effective in preventing HIV infection in cisgender women: interim results from HPTN 084. J Int AIDS Soc. 2021;24(S1):8\u20139.","journal-title":"J Int AIDS Soc"},{"issue":"2","key":"621_CR83","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1093\/jac\/dkab324","volume":"77","author":"P Thoueille","year":"2022","unstructured":"Thoueille P, et al. Long-acting antiretrovirals: a new era for the management and prevention of HIV infection. J Antimicrob Chemother. 2022;77(2):290\u2013302.","journal-title":"J Antimicrob Chemother"},{"key":"621_CR84","unstructured":"Organization W.H. WHO recommends the dapivirine vaginal ring as a new choice for HIV prevention for women at substantial risk of HIV infection. WHO News. 2021."},{"issue":"3","key":"621_CR85","doi-asserted-by":"publisher","first-page":"e164","DOI":"10.1016\/S2352-3018(19)30372-8","volume":"7","author":"D Sch\u00fcrmann","year":"2020","unstructured":"Sch\u00fcrmann D, et al. Safety, pharmacokinetics, and antiretroviral activity of islatravir (ISL, MK-8591), a novel nucleoside reverse transcriptase translocation inhibitor, following single-dose administration to treatment-naive adults infected with HIV-1: an open-label, phase 1b, consecutive-panel trial. Lancet HIV. 2020;7(3):e164\u201372.","journal-title":"Lancet HIV"},{"issue":"8","key":"621_CR86","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1097\/QAD.0000000000002211","volume":"33","author":"J Pintye","year":"2019","unstructured":"Pintye J, et al. Acceptability and outcomes of distributing HIV self-tests for male partner testing in Kenyan maternal and child health and family planning clinics. AIDS (London, England). 2019;33(8):1369\u201378.","journal-title":"AIDS (London, England)"},{"key":"621_CR87","doi-asserted-by":"crossref","unstructured":"Jarolimova J, et al. Curable sexually transmitted infections among women with HIV in sub-Saharan Africa: systematic review and meta-analysis. AIDS (London, England). 2022.","DOI":"10.1097\/QAD.0000000000003163"},{"key":"621_CR88","doi-asserted-by":"crossref","unstructured":"Mashaphu S, et al. Condom use consistency among South African HIV serodiscordant couples following an HIV risk-reduction intervention. Int J STD AIDS. 2022;09564624221076617.","DOI":"10.1177\/09564624221076617"},{"issue":"3","key":"621_CR89","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.4314\/ahs.v21i3.48","volume":"21","author":"PD Shallie","year":"2021","unstructured":"Shallie PD, Haffejee F. Systematic review and meta-analysis assessing the knowledge and use of the female condom among Nigerians. Afr Health Sci. 2021;21(3):1362\u201374.","journal-title":"Afr Health Sci"}],"container-title":["Current HIV\/AIDS Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11904-022-00621-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11904-022-00621-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11904-022-00621-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T12:25:36Z","timestamp":1663935936000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11904-022-00621-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,19]]},"references-count":89,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["621"],"URL":"https:\/\/doi.org\/10.1007\/s11904-022-00621-1","relation":{},"ISSN":["1548-3568","1548-3576"],"issn-type":[{"value":"1548-3568","type":"print"},{"value":"1548-3576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,19]]},"assertion":[{"value":"20 July 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This is a review, and no human subjects were involved in the production of this research piece. No consent to participate or for publication applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"MLM reports grants from the National Institutes of Health (NIH) and the Bill and Melinda Gates Foundation. GJ-S reports grants from NIH, CDC, Thrasher Foundation, IMPAACT and stock options from the Malaika HIV vaccine outside the submitted work. GJ-S sits on the DSMB of the VITALITY and Tatelo trials. RVB reports grants from NIH and the Bill and Melinda Gates Foundation; and conference abstract and manuscript writing support from Regeneron Pharmaceuticals, outside the submitted work.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}